AI Article Synopsis

  • Identifying cancer early is difficult, and selecting the right sample type for diagnosis is crucial.
  • The study compared whole blood and serum samples of breast cancer using laser-induced breakdown spectroscopy (LIBS) and various machine learning models for analysis.
  • Whole blood samples outperformed serum samples in prediction accuracy (91.7% vs. 89.7%) and showed stronger spectral emission lines, suggesting they're a better option for breast cancer detection.

Article Abstract

To identify cancer from non-cancer is one of the most challenging issues nowadays in the early diagnosis of cancer. The primary issue of early detection is to choose a suitable type of sample collection to diagnose cancer. A comparison of whole blood and serum samples of breast cancer was studied using laser-induced breakdown spectroscopy (LIBS) with machine learning methods. For LIBS spectra measurement, blood samples were dropped on a substrate of boric acid. For the discrimination of breast cancer and non-cancer samples, eight machine learning models were applied to LIBS spectral data, including decision tree, discrimination analysis, logistic regression, naïve byes, support vector machine, k-nearest neighbor, ensemble and neural networks classifiers. Discrimination between whole blood samples showed that narrow neural networks and trilayer neural networks both provided 91.7% highest prediction accuracy and serum samples showed that all the decision tree models provided 89.7% highest prediction accuracy. However, using whole blood as sample achieved the strong emission lines of spectra, better discrimination results of PCA and maximum prediction accuracy of machine learning models as compared to using serum samples. These merits concluded that whole blood samples could be a good option for the rapid detection of breast cancer. This preliminary research may provide the complementary method for early detection of breast cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278612PMC
http://dx.doi.org/10.1364/BOE.489513DOI Listing

Publication Analysis

Top Keywords

breast cancer
20
serum samples
16
machine learning
16
blood samples
12
neural networks
12
prediction accuracy
12
comparison blood
8
blood serum
8
samples
8
samples breast
8

Similar Publications

Background: Breast cancer is a frequently diagnosed malignant disease and the primary cause of mortality among women with cancer worldwide. The therapy options are influenced by the molecular subtype due to the intricate nature of the condition, which consists of various subtypes. By focusing on the activation of receptors, Epidermal Growth Factor Receptor (EGFR) tyrosine kinase can be utilized as an effective drug target for therapeutic purposes of breast cancer.

View Article and Find Full Text PDF

Introduction: Management of pain associated with breast cancer surgeries is crucial in reducing incidence of postmastectomy pain syndrome. The pain distribution involves the anterior chest wall, axillary area and ipsilateral upper limb.

Objective: This study was designed to investigate the effect of bilevel erector spinae plane block (ESPB) with high thoracic block vs the conventional unilevel ESPB vs opioids in patients with cancer undergoing modified radical mastectomy regarding pain control and reducing pain in axilla.

View Article and Find Full Text PDF

Background: Breast cancer is the most common cancer among women. In response to the need to hospital stays and minimize waiting time for surgery, particularly during the COVID-19 pandemic, the National Cancer Institute developed the One Day Surgery with Breast cancer Home Recovery program (ODS BHR NCI). The aim of study is to assess the success rate of breast cancer surgeries conducted through this program and to evaluate the incidence of complications.

View Article and Find Full Text PDF

Immunogenic cell death (ICD) offers a promising avenue for the treatment of triple-negative breast cancer (TNBC). However, optimizing immune responses remains a formidable challenge. This study presents the design of RBCm@Pt-CoNi layered double hydroxide (RmPLH), an innovative sonosensitizer for sonodynamic therapy (SDT), aimed at enhancing the efficacy of programmed cell death protein 1 (PD-1) inhibitors by inducing robust ICD responses.

View Article and Find Full Text PDF

Cancer remains a leading cause of mortality, with aggressive, treatment-resistant tumors posing significant challenges. Current combination therapies and imaging approaches often fail due to disparate pharmacokinetics and difficulties correlating drug delivery with therapeutic response. In this study, we developed radionuclide-activatable theranostic nanoparticles (NPs) comprising folate receptor-targeted bimetallic organo-nanoparticles (Gd-Ti-FA-TA NPs).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!